Fulcrum Therapeutics (FULC) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Understanding Accounting and Bookkeeping Services for Business Success

June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success

Every successful business relies on accurate financial records. From managing cash flow to ensuring compliance with tax regulations, reliable accounting and bookkeeping services…
How much does a Turkish passport cost?

May 27, 2025 How much does a Turkish passport cost?

Turkish citizenship comes with numerous benefits. Once granted, a foreigner can enter 126 countries visa-free, enjoy high-quality healthcare and favorable tax regimes, and…
How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…
Are you making these mistakes when analyzing candlestick patterns?

May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?

Trading is a very popular endeavor these days, and for good reason, as it is widely accessible and allows individuals to generate additional…
Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…

Fulcrum Therapeutics (FULC) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: June 18, 2025 (14:37)

Sector: Healthcare

The share price of Fulcrum Therapeutics, Inc. (FULC) now

Latest session on the 17th of June for
Fulcrum Therapeutics, Inc. is negative
Trading Volume: 685257
Open: 6.78 /  High: 6.87 /  Low: 6.33
Current value: $6.43
What analysts predict: $7.57
52-week High/Low: $10.13 / $2.315
50-Day Moving Average: $4.335 — support level today
200-Day Moving Average: $4.405 — support level today

Are you interested in Fulcrum Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Fulcrum Therapeutics stock price in 2025, 2026, 2027. How much will one Fulcrum Therapeutics share be worth in 2025 - 2027?

When should I take profit in Fulcrum Therapeutics stock? When should I record a loss on Fulcrum Therapeutics stock? What are analysts' forecasts for Fulcrum Therapeutics stock? What is the future of Fulcrum Therapeutics stock? We forecast Fulcrum Therapeutics stock performance using neural networks based on historical data on Fulcrum Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Fulcrum Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Fulcrum Therapeutics shares. This happens once a day.


Historical and forecast chart of Fulcrum Therapeutics stock

The chart below shows the historical price of Fulcrum Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Fulcrum Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Fulcrum Therapeutics is a biopharmaceutical company that develops drugs to treat genetic diseases. The company has developed product candidates to modulate gene expression and potentially treat the underlying cause of these diseases.

Trending Themes in the Healthcare Sector

Fulcrum Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 20 6.63 6.46 6.73 4.11
Jun 21 6.69 6.62 6.90 4.24
Jun 22 6.73 6.56 6.88 4.76
Jun 23 6.54 6.41 6.65 3.67
Jun 24 6.73 6.60 6.82 3.39
Jun 25 6.87 6.79 7.04 3.60
Jun 26 6.94 6.87 7.02 2.22
Jun 27 7.07 6.87 7.21 4.85
Jun 28 7.23 7.06 7.44 5.36
Jun 29 7.10 6.96 7.19 3.35
Jun 30 7.10 7.03 7.17 1.98
Jul 01 7.11 7.01 7.24 3.28
Jul 02 7.33 7.11 7.55 6.10
Jul 03 7.51 7.44 7.66 3.07
Jul 04 7.37 7.31 7.55 3.35
Jul 05 7.36 7.17 7.46 4.06
Jul 06 7.32 7.26 7.55 4.04
Jul 07 7.41 7.20 7.53 4.57
Jul 08 7.27 7.12 7.46 4.70
Jul 09 7.26 7.11 7.35 3.39
Jul 10 7.14 6.99 7.30 4.37
Jul 11 7.10 6.95 7.22 3.88
Jul 12 7.34 7.27 7.52 3.39
Jul 13 7.26 7.03 7.41 5.37
Jul 14 7.47 7.25 7.67 5.77
Jul 15 7.37 7.29 7.52 3.15
Jul 16 7.51 7.44 7.64 2.70
Jul 17 7.49 7.39 7.57 2.43
Jul 18 7.32 7.17 7.55 5.31
Jul 19 7.30 7.21 7.47 3.52

Fulcrum Therapeutics Daily Price Targets


Fulcrum Therapeutics Stock Forecast 06-20-2025.

Forecast target price for 06-20-2025: $6.63.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.943%.
Pessimistic target level: 6.46
Optimistic target level: 6.73

Fulcrum Therapeutics Stock Forecast 06-21-2025.

Forecast target price for 06-21-2025: $6.69.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 4.070%.
Pessimistic target level: 6.62
Optimistic target level: 6.90

Fulcrum Therapeutics Stock Forecast 06-22-2025.

Forecast target price for 06-22-2025: $6.73.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 4.540%.
Pessimistic target level: 6.56
Optimistic target level: 6.88

Fulcrum Therapeutics Stock Forecast 06-23-2025.

Forecast target price for 06-23-2025: $6.54.
Negative dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.542%.
Pessimistic target level: 6.41
Optimistic target level: 6.65

Fulcrum Therapeutics Stock Forecast 06-24-2025.

Forecast target price for 06-24-2025: $6.73.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.277%.
Pessimistic target level: 6.60
Optimistic target level: 6.82

Fulcrum Therapeutics Stock Forecast 06-25-2025.

Forecast target price for 06-25-2025: $6.87.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.475%.
Pessimistic target level: 6.79
Optimistic target level: 7.04

FULC (FULC) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jul. 7.78 6.85 9.01 24.01
Aug. 8.68 7.83 10.02 21.84
Sep. 8.89 7.88 9.62 18.11
Oct. 9.14 8.15 9.65 15.53
Nov. 9.53 8.86 10.94 18.99
Dec. 8.93 8.06 9.56 15.70

Fulcrum Therapeutics forecast for this year


Fulcrum Therapeutics Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $7.78128. Pessimistic: $6.85. Optimistic: $9.01


Fulcrum Therapeutics Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $8.68391. Pessimistic: $7.83. Optimistic: $10.02


Fulcrum Therapeutics Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $8.89232. Pessimistic: $7.88. Optimistic: $9.62


Fulcrum Therapeutics Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $9.14131. Pessimistic: $8.15. Optimistic: $9.65


Fulcrum Therapeutics Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $9.52524. Pessimistic: $8.86. Optimistic: $10.94


Fulcrum Therapeutics Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $8.93468. Pessimistic: $8.06. Optimistic: $9.56



Fulcrum Therapeutics (FULC) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 10.54 9.11 11.15 18.34
Feb 10.67 10.01 11.72 14.57
Mar 11.35 10.08 11.92 15.43
Apr 11.35 10.15 12.76 20.46
May 12.28 10.64 13.02 18.30
Jun 10.69 10.02 11.67 14.10
Jul 10.94 10.42 11.99 13.14
Aug 12.91 11.75 13.66 13.99
Sep 14.77 12.53 16.90 25.87
Oct 13.80 13.16 15.20 13.43
Nov 13.69 12.81 15.08 15.06
Dec 16.10 15.13 17.29 12.48

Fulcrum Therapeutics (FULC) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 16.87 15.86 18.93 16.22
Feb 15.38 13.08 16.92 22.73
Mar 15.01 13.75 16.07 14.39
Apr 16.34 15.29 17.45 12.36
May 13.92 13.14 15.39 14.65
Jun 12.67 10.64 13.17 19.23
Jul 12.54 10.61 14.44 26.56
Aug 14.24 13.67 14.98 8.74
Sep 15.24 13.81 16.70 17.34
Oct 13.26 11.27 14.82 23.97
Nov 14.43 13.73 16.30 15.75
Dec 12.55 11.02 13.25 16.86

Fulcrum Therapeutics information and performance

Fulcrum Therapeutics Address

26 LANDSDOWNE STREET, CAMBRIDGE, MA, US

Market Capitalization: 375 696 000 $

Market capitalization of the Fulcrum Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of FULC shares in the company outstanding by the market price of one share.

EBITDA: -8 936 000 $

EBITDA of Fulcrum Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.01

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -1
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.908

Enterprise Value (EV) /Revenue

EV To EBITDA: -3.095

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 53979000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Fulcrum Therapeutics Stock)

Should I Buy Fulcrum Therapeutics Shares in 2025 year?

The maximum forecasted share price for next year is $16.10, which is $9.67 higher than the current stock price. By investing in Fulcrum Therapeutics shares today for a one-year period, you could achieve a profit of 150.32%. With an investment horizon of up to two years, the target share price is $16.87. resulting in a profit of 162.33% ($10.44 per share).

Does Fulcrum Therapeutics pay dividends?

No, it does not

Which economic sector do Fulcrum Therapeutics's shares belong to?

Fulcrum Therapeutics's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Fulcrum Therapeutics's shares?

You can view all the stocks that are part of the same sector as Fulcrum Therapeutics's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.